Chester County News and Community Website
Galera Therapeutics, Inc. (Nasdaq: GRTX), headquartered in Malvern, PA, is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
CAMBRIDGE, MA & MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) and Obsidian Therapeutics, Inc. recently entered into a definitive merger agreement in an all-stock transaction and secured commitments for …
Galera, Obsidian Agree to Merge, Raise $350 Million in Financing Read More
CAMBRIDGE, MA & MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) and Obsidian Therapeutics, Inc. recently entered into a definitive agreement to merge in an all-stock transaction, with the combined …
Galera, Obsidian to Merge, Raise $350 Million in Financing Read More MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) announced it has entered into an asset purchase agreement with Toronto-based Biossil Inc. for the sale of its dismutase mimetics portfolio, including …
Galera Therapeutics Sells Dismutase Mimetics Portfolio to Biossil in $108.5 Million Deal Read More MALVERN, PA — Galera Therapeutics, Inc. (OTC: GRTX) has announced its acquisition of Nova Pharmaceuticals, Inc., a biotechnology company focused on treating resistant forms of breast cancer, including metaplastic and …
Galera Therapeutics Acquires Nova Pharmaceuticals to Advance Breast Cancer Treatment Read More